Abstract: Materials and Methods are provided for making plants (e.g., Nicotiana varieties) that are suitable for producing therapeutic polypeptides suitable for administration to humans and animals, particularly by making TAL effector endonuclease-induced mutations in genes encoding xylosyltransferases and fucosyltransferases.
Abstract: The present invention concerns a method for in vivo generation of a linear polynucleotide with 5? and 3? free ends from a vector having no free end, said linear polynucleotide being integrated into the host cell genome. The vector having no free end according to the present invention comprise the polynucleotide to be linearized or excised flanked by a cleavage site, said cleavage site being preferably not found in the host cell genome. The present invention also relates to the resulting cells and their uses, for example for production of proteins or other genes, biomolecules, biomaterials, transgenic plants, vaccines, transgenic animals or for treatment or prophylaxis of a condition or disorder in an individual.
Type:
Grant
Filed:
September 13, 2002
Date of Patent:
August 29, 2006
Assignee:
Cellectis SA
Inventors:
Andre Choulika, Jean-Stephane Joly, Violette Thermes, Filomena Ristoratore